Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq pulled back to their respective 50-
DMA before finding support and closing within the upper half of their weekly range. Support below the 50-DMA
is ~4,233 on the S&P 500 and ~14,200 on the Nasdaq. Despite adding a distribution day on Tuesday, the
overall count declined to three and two, respectively, with no expiration next week.

O’Neil Health Care Weekly

Over the last five sessions, Generic Drugs ( OGN ), Diversified Healthcare ( GSK ), and Pharmaceuticals ( PFE ) led, while
Hospitals ( LFST ), Services  ( NVTA ), and Long-term Care ( OSH ) lagged. Hospitals, Diversified Healthcare,
Pharmaceuticals, and Systems/Equipment remain top-ranked industry groups. Biotech, Long-term Care, Services, and
Outpatient Care are trading below 50- and 200-DMA.

IPO Rewind

Winners (annualized gain of 30% or greater)
• Less than half the median market cap at IPO and clearly better Day 1 performance.
• Revenue growth of ~40% three consecutive years (1 year prior to IPO, year of IPO, and year after IPO).
• Most still losing money as they IPO, but more make progress toward profits.

Losers (annualized loss of 20% or greater)
• Clearly larger IPOs, not as good Day 1 performance.
• Good revenue growth year before IPO and year of IPO (although sharply lagging winners), but big dropoff in revenue growth year after IPO.
• Similar % losing money, but difference with that no progress in the group made over three years.

Market View

U.S. Market
The U.S. market remains in a Confirmed Uptrend. The S&P 500 is trending into all-time highs, while the Nasdaq
continues to consolidate within 1% of a new high and above 21-DMA support. Distribution has mostly been
avoided over the last two weeks, with the count now standing at four each, with two set to expire on the S&P 500
and three on the Nasdaq next week.

O’Neil Health Care Weekly

XLV remains within 1% of all-time highs after a small pullback to its 10-DMA to close last week. The majority of big cap constituents are holding near highs with only a select few reacting negatively to earnings. The RS line pulled back slightly, but is still holding a recent uptrend.

 

Currently, most ideas have become extended from ideal entry points. We recommend holding high RS ideas that are not abnormally extended versus short- and long-term moving averages versus how they typically trade. We will be looking for ideas to consolidate over the coming weeks to provide alternative entry points

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq closed the week at or near new

highs and above all major moving averages, including near-term support along the 10- and 21-DMA. The dis-
tribution day count stands at six and four, respectively, with two days expiring on the S&P 500 next week.

O’Neil Health Care Weekly

XLV is trending into higher highs, remaining above both its 10- and 21-DMA. Its RS line is now rising versus the S&P 500
as a multitude of big cap constituents remain at highs post print.
We have also seen many secular growth ideas breakout in explosive fashion from six-month to year-long bases over the
past week including ALGN, DXCM, and RGEN among others. Continue to increase risk in these ideas as we believe
these breakouts will likely lead to trending action over the next several weeks to months

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq traded relatively flat for the week,
remaining within 1% of a new high and above near-term support along the 21-DMA. The longer-term lower end
of support remains the rising 50-DMA on both indices. Upside resistance is still along the rising upper channel
line which is above 4,500 on the S&P 500 and above 15,300 on the Nasdaq. The distribution day count stands
at six and three, respectively, with no expiration next week.

O’Neil Health Care Weekly

XLV gapped into another new all-time high last week after trading relatively flat for two weeks. Its RS line is still flat versus
a strong S&P 500 despite a multitude of big cap quality secular growth ideas also trading at new highs.
The majority of ideas are extended from ideal entry points, therefore we recommend a patient approach to adding risk.
Focus on high relative strength ideas as they form the right side of bases ideally in heavy volume, while also looking to
increase risk in leading ideas that constructively pull back to logical support.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq rallied strongly off 50-DMA sup-
port early this week before gapping back to new all-time highs on Friday. Both are now pushing back toward

their respective upper channel lines, which are above 4,500 on the S&P 500 and 15,100 on the Nasdaq. Sup-
port is again the rising 10- and 21-DMA. The distribution day count declined to four and three, respectively, with

no further expiration for two weeks.